<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-09-18T20:34:36Z</responseDate>
  <request identifier="oai:figshare.com:article/32346996" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/32346996</identifier>
        <datestamp>2026-05-21T11:43:12Z</datestamp>
        <setSpec>portal_1132</setSpec>
        <setSpec>item_type_8</setSpec>
        <setSpec>month_year_05_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Characterising the functional  homology of central nervous  system drug targets in larval  zebrafish (Danio rerio)</dc:title>
          <dc:creator>Siobhân Alexandra Monaghan (23946420)</dc:creator>
          <dc:creator>Siobhan Monaghan (21040757)</dc:creator>
          <dc:subject>Uncategorised value</dc:subject>
          <dc:description>Pharmaceuticals are increasingly detected in aquatic environments at concentrations 
ranging from ng/L to mg/L, yet their potential impacts on non-target organisms remain poorly 
understood. Central nervous system (CNS)-targeting drugs are of particular concern 
because they are designed to act at low concentrations on highly conserved molecular 
targets. While sequence-level conservation of these targets between humans and fish is well 
established, it remains unclear whether this translates into functional conservation in terms 
of physiological and neurobiological responses. Addressing this gap is critical for improving 
environmental risk assessment frameworks, which currently rely largely on apical toxicity 
endpoints and consider pharmacological mode of action to a lesser degree. 
This thesis investigates whether conservation of CNS drug targets in fish predicts functional 
effects, using larval zebrafish (Danio rerio) as a model system. The study focuses on nine 
widely prescribed and environmentally relevant compounds: three anticonvulsants 
(carbamazepine, lamotrigine, gabapentin), three antidepressants (venlafaxine, escitalopram, 
trazodone), and three antipsychotics (aripiprazole, clozapine, risperidone). 
Chapter 1 reviews the occurrence, mechanisms of action, and environmental relevance of 
CNS-active pharmaceuticals, identifying key knowledge gaps in linking molecular 
conservation to ecological outcomes. Major neurotransmitter systems, including 
serotonergic, dopaminergic, glutamatergic, GABAergic, cholinergic, and adrenergic 
pathways, are shown to be highly conserved between humans and fish. 
Chapter 2 examines the evolutionary conservation of CNS drug targets across ray-finned 
fish using bioinformatic analyses of 67 species from the Ensembl database. High levels of 
sequence and binding site conservation were identified across multiple receptor families and 
ion channels, including dopaminergic, serotonergic, and histaminergic receptors, as well as 
voltage-gated Na⁺ and Ca²⁺ channels. However, gene duplication and the presence of 
3 
paralogues introduce complexity in predicting functional equivalence, highlighting limitations 
of sequence-based approaches alone. 
Chapter 3 evaluates uptake and developmental toxicity of the selected compounds using a 
modified OECD fish embryo toxicity assay in larval zebrafish. Compound-specific differences 
in bioconcentration and toxicity were observed, and bioconcentration factors (BCFs) were 
determined for 8 of the 9 compounds. The uptake of gabapentin was below the instruments 
limit of detection. Sub-lethal endpoints, including touch responsiveness, were sensitive to 
exposure. This chapter also established no observable effect concentrations (NOECs), 
which informed exposure levels for subsequent functional analyses. 
Chapter 4 investigates the neurophysiological effects of chronic exposure using whole-brain 
Ca²⁺ imaging. Distinct, drug-specific alterations in neural activity were observed, with region
specific responses across multiple regions. Most compounds produced a unique pattern of 
neural activation and suppression, although risperidone showed no measurable effect under 
the conditions tested. Interestingly. gabapentin demonstrated significant impact on neural 
activity patterns, despite showing no measurable uptake in chapter 2. Functional 
connectivity analysis demonstrated that trazodone exposure alters functional connectivity 
providing direct evidence of pharmacologically relevant effects on the fish CNS. 
Chapter 5 assesses molecular responses using quantitative polymerase chain reaction 
(qPCR). Most gene expression changes were not statistically significant; however, increased 
expression of htr2cl1 was observed following exposure to a human therapeutically relevant 
concentration of escitalopram. Additionally, differential expression of the paralogues drd2a 
and drd2b was identified following exposure to aripiprazole, with no differences observed in 
paralogue expression within controls. These molecular responses did not consistently align 
with neural activity patterns or predicted target conservation. 
Together, these findings demonstrate that while CNS drug targets are highly conserved at 
the molecular level and most compounds were taken up by larvae, conservation and uptake 
4 
do not reliably predict functional outcomes. Instead, biological responses are influenced by a 
combination of target conservation, bioavailability, and system-level neural dynamics. 
This work provides a mechanistic framework linking molecular conservation to functional 
effects in aquatic organisms and highlights the importance of integrating pharmacological 
knowledge into environmental risk assessment. By combining bioinformatics, toxicology, 
neuroimaging, and molecular biology, this thesis advances understanding of how 
neuroactive pharmaceuticals impact non-target species and underscores the need to 
consider evolutionary and functional context when assessing environmental risk.&lt;p&gt;&lt;/p&gt;</dc:description>
          <dc:date>2026-05-20T00:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Thesis</dc:type>
          <dc:identifier>10779/exe.32346996.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/thesis/Characterising_the_functional_homology_of_central_nervous_system_drug_targets_in_larval_zebrafish_Danio_rerio_/32346996</dc:relation>
          <dc:rights>All rights reserved</dc:rights>
          <dc:rights>Open Access after 2027-05-21</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
